Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
278.19
-7.42 (-2.60%)
At close: Oct 31, 2025, 4:00 PM EDT
278.89
+0.70 (0.25%)
After-hours: Oct 31, 2025, 7:11 PM EDT
Humana Market Cap
Humana has a market cap or net worth of $33.46 billion as of October 31, 2025. Its market cap has increased by 8.73% in one year.
Market Cap
33.46B
Enterprise Value
42.34B
1-Year Change
8.73%
Ranking
Category
Stock Price
$278.19
Market Cap Chart
Since December 1, 1998, Humana's market cap has increased from $3.36B to $33.46B, an increase of 896.47%. That is a compound annual growth rate of 8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 33.46B | 9.52% |
| Dec 31, 2024 | 30.55B | -45.80% |
| Dec 29, 2023 | 56.36B | -13.08% |
| Dec 30, 2022 | 64.84B | 8.76% |
| Dec 31, 2021 | 59.62B | 9.81% |
| Dec 31, 2020 | 54.30B | 11.87% |
| Dec 31, 2019 | 48.54B | 23.50% |
| Dec 31, 2018 | 39.30B | 10.90% |
| Dec 29, 2017 | 35.44B | 16.50% |
| Dec 30, 2016 | 30.42B | 14.97% |
| Dec 31, 2015 | 26.46B | 20.14% |
| Dec 31, 2014 | 22.02B | 36.85% |
| Dec 31, 2013 | 16.09B | 48.20% |
| Dec 31, 2012 | 10.86B | -24.19% |
| Dec 30, 2011 | 14.32B | 55.47% |
| Dec 31, 2010 | 9.21B | 23.61% |
| Dec 31, 2009 | 7.45B | 18.51% |
| Dec 31, 2008 | 6.29B | -50.71% |
| Dec 31, 2007 | 12.76B | 38.78% |
| Dec 29, 2006 | 9.19B | 3.96% |
| Dec 30, 2005 | 8.84B | 86.87% |
| Dec 31, 2004 | 4.73B | 28.57% |
| Dec 31, 2003 | 3.68B | 122.75% |
| Dec 31, 2002 | 1.65B | -16.91% |
| Dec 31, 2001 | 1.99B | -22.25% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |